Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td class="align_left">Groups</td><td class="align_center">ALX (mg/kg)</td><td class="align_center">Total mice</td><td class="align_center">T1DM mice</td><td class="align_center">T1DM incidence (%)</td><td class="align_center"><svg height="10.108pt" id="M47" style="vertical-align:-3.23369pt" version="1.1" viewbox="-0.0498162 -6.87431 8.20288 10.108" width="8.20288pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M600 297C600 402 548 454 439 454C406 454 381 453 344 444L365 522L353 528C314 514 254 479 229 455L218 414C184 403 146 388 113 365L123 331C148 346 175 358 208 367L107 -123C95 -180 77 -195 16 -207L9 -241L298 -229L304 -193L287 -192C232 -189 218 -179 229 -125L254 -3C275 -10 291 -12 312 -12C380 4 464 50 513 103C570 165 600 241 600 297ZM465 297C465 180 383 35 323 35C309 35 281 53 271 68L335 394C346 397 360 400 380 400C422 400 465 382 465 297Z"></path></g></svg> value</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td class="align_left">WT</td><td class="align_center">60</td><td class="align_center">20</td><td class="align_center">15</td><td class="align_center">75</td><td class="align_center">—</td></tr><tr><td class="align_left">Nrf2<sup>-/-</sup></td><td class="align_center">60</td><td class="align_center">16</td><td class="align_center">16</td><td class="align_center">100</td><td class="align_center"><span style="width: 50.7895ptpx;"><svg height="11.7782pt" id="M48" style="vertical-align:-3.42938pt" version="1.1" viewbox="-0.0498162 -8.34882 50.7895 11.7782" width="50.7895pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M570 304C570 398 525 448 414 448C385 448 343 445 312 434L329 511L321 518C297 504 262 482 244 460L233 411C195 397 159 381 128 358L135 332C160 347 189 360 224 373L111 -147C97 -210 84 -218 17 -231L13 -257L254 -247L259 -218L233 -216C183 -212 177 -202 189 -142L218 -1C238 -10 266 -12 283 -12C351 3 429 48 483 105C543 168 570 242 570 304ZM482 289C482 161 380 33 304 33C278 33 248 51 233 69L303 396C326 400 352 403 369 403C428 403 482 380 482 289Z"></path></g><g transform="matrix(.013,0,0,-0.013,11.342,0)"><path d="M512 -3V55L134 254V256L512 456V514L75 281V230L512 -3Z"></path></g><g transform="matrix(.013,0,0,-0.013,22.605,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,28.845,0)"><path d="M113 -12C146 -12 170 11 170 46C170 78 146 103 114 103S58 78 58 46C58 11 82 -12 113 -12Z"></path></g><g transform="matrix(.013,0,0,-0.013,31.809,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,38.049,0)"><path d="M241 635C89 635 35 457 35 312C35 153 89 -12 240 -12C390 -12 443 166 443 312C443 466 390 635 241 635ZM238 602C329 602 354 454 354 312C354 172 330 22 240 22C152 22 124 173 124 313S148 602 238 602Z"></path></g><g transform="matrix(.013,0,0,-0.013,44.289,0)"><path d="M384 0V27C293 34 287 42 287 114V635C232 613 172 594 109 583V559L157 557C201 555 205 550 205 499V114C205 42 199 34 109 27V0H384Z"></path></g></svg></span></td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of ALX-stimulated T1DM incidence between WT and Nrf2<sup>-/-</sup> C57BL/6J mice.</div>

Oxidative Medicine and Cellular Longevity

tab1

Table 1

Table 1: Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus 